Ozmosi | Teprenone Drug Profile
Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

Teprenone

Alternative Names: teprenone, geranylgeranylacetone, selbex
Clinical Status: Active
Latest Update: 2025-04-01
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: PG Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Colombia | Dominican Republic | Jordan | Korea | Pakistan

Approved Indications: None

Known Adverse Events: None

Company: Guowei Pharmaceutical
Company Location: Asia Pacific
Company CEO:
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Teprenone

Countries in Clinic: China

Active Clinical Trial Count: 1

Recent & Upcoming Milestones

Highest Development Phases

Phase 2: Gastritis

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

CTR20130427

 CTR20130427

P2

Active, not recruiting

Gastritis

None

2025-04-29

Treatments

Recent News Events

Date

Type

Title

05/02/2024

PubMed

 The suppression of HSPA8 attenuates NLRP3 ubiquitination through SKP2 to promote pyroptosis in sepsis-induced lung injury.

04/29/2024

PubMed

 Short-term dietary teprenone improved thermal tolerance and mitigated liver damage caused by heat stress in juvenile largemouth bass (Micropterus salmoides).

04/17/2024

PubMed

 Proteome, lysine acetylome and succinylome identify post-translational modification of STAT1 as a novel drug target in silicosis.

09/08/2023

News Article

 Gastric Mucosal Protective Agent market research report was developed using extensive primary and secondary research with estimated CAGR 8.1% for Period 2023-2030

05/18/2020

News Article

 Eisai to Launch New Selbelle Premium Tablets and New Selbelle Premium Fine Granules

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions